Starpharma Holdings Ltd (SPL) - Total Liabilities

Latest as of December 2025: AU$4.69 Million AUD ≈ $3.32 Million USD

Based on the latest financial reports, Starpharma Holdings Ltd (SPL) has total liabilities worth AU$4.69 Million AUD (≈ $3.32 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Starpharma Holdings Ltd - Total Liabilities Trend (2000–2025)

This chart illustrates how Starpharma Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. See Starpharma Holdings Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Starpharma Holdings Ltd Competitors by Total Liabilities

The table below lists competitors of Starpharma Holdings Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
HMS Bergbau AG XETRA:HMU	Germany	€175.91 Million
BVZ Holding AG SW:BVZN	Switzerland	CHF436.12 Million
Goknur Gida Maddeleri Enerji Imalati Ithalat Ihracat Ticaret ve Sanayi A.S. IS:GOKNR	Turkey	TL3.67 Billion
UNISEM Co. Ltd KQ:036200	Korea	₩42.73 Billion
Chicago Atlantic BDC, Inc. NASDAQ:LIEN	USA	$38.59 Billion
Xiwang Foodstuffs Co Ltd SHE:000639	China	CN¥2.58 Billion
Bank Amar Indonesia JK:AMAR	Indonesia	Rp2.21 Trillion
Voyager Therapeutics Inc NASDAQ:VYGR	USA	$68.49 Million

Liability Composition Analysis (2000–2025)

This chart breaks down Starpharma Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SPL market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.26	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	3.96	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Starpharma Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Starpharma Holdings Ltd (2000–2025)

The table below shows the annual total liabilities of Starpharma Holdings Ltd from 2000 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$6.42 Million ≈ $4.54 Million	-26.16%
2024-06-30	AU$8.70 Million ≈ $6.15 Million	-49.64%
2023-06-30	AU$17.27 Million ≈ $12.22 Million	-2.87%
2022-06-30	AU$17.78 Million ≈ $12.58 Million	+62.57%
2021-06-30	AU$10.94 Million ≈ $7.74 Million	+41.10%
2020-06-30	AU$7.75 Million ≈ $5.49 Million	+19.93%
2019-06-30	AU$6.46 Million ≈ $4.57 Million	+23.50%
2018-06-30	AU$5.23 Million ≈ $3.70 Million	-6.65%
2017-06-30	AU$5.61 Million ≈ $3.97 Million	-41.68%
2016-06-30	AU$9.62 Million ≈ $6.80 Million	+40.88%
2015-06-30	AU$6.83 Million ≈ $4.83 Million	+74.51%
2014-06-30	AU$3.91 Million ≈ $2.77 Million	+51.47%
2013-06-30	AU$2.58 Million ≈ $1.83 Million	-54.03%
2012-06-30	AU$5.62 Million ≈ $3.97 Million	+165.70%
2011-06-30	AU$2.11 Million ≈ $1.50 Million	-22.37%
2010-06-30	AU$2.72 Million ≈ $1.93 Million	-18.67%
2009-06-30	AU$3.35 Million ≈ $2.37 Million	-21.59%
2008-06-30	AU$4.27 Million ≈ $3.02 Million	-9.14%
2007-06-30	AU$4.70 Million ≈ $3.33 Million	+27.11%
2006-06-30	AU$3.70 Million ≈ $2.62 Million	+45.91%
2005-06-30	AU$2.53 Million ≈ $1.79 Million	+182.02%
2004-06-30	AU$898.45K ≈ $635.71K	-38.98%
2003-06-30	AU$1.47 Million ≈ $1.04 Million	-7.58%
2002-06-30	AU$1.59 Million ≈ $1.13 Million	+43.55%
2001-06-30	AU$1.11 Million ≈ $785.26K	+456.90%
2000-06-30	AU$199.28K ≈ $141.00K	--

About Starpharma Holdings Ltd

AU:SPL Australia Biotechnology

Market Cap

$206.99 Million

AU$292.55 Million AUD

Market Cap Rank

#16492 Global

#463 in Australia

Share Price

AU$0.70

Change (1 day)

-0.71%

52-Week Range

AU$0.09 - AU$0.76

All Time High

AU$2.49